Brachytherapy’s 2026 Prostate Cancer Revolution
Prostate cancer brachytherapy now boasts 95.8% five-year recurrence-free survival. See how AI, MRI guidance, and adaptive plans improve outcomes.
Prostate cancer brachytherapy now boasts 95.8% five-year recurrence-free survival. See how AI, MRI guidance, and adaptive plans improve outcomes.
Understand 3 focused radiation therapies like SBRT and proton therapy. Learn how they target tumors precisely, reducing side effects by up to 30%.
Brands face fragmented CTV measurement. Learn why unified solutions, impression-based data, and fraud detection are key to accurate ROI by 2027.
New non-surgical tear trough treatment rhPDGF-BB offers collagen growth for infraorbital hollowing. See USC's 2026 trial results.
Publicis Sapient and Schneider Electric use AI to cut industrial energy 30% by 2027. See how AI reduces carbon footprint and costs.
Accenture reports 85% of enterprise tech projects fail. Learn why so many overhauls miss goals and key steps to succeed with your next initiative.
Kyndryl's report shows 75% of enterprises boosting AI by 2026. See key tech priorities for growth, resilience, and what matters for your business.
Kyndryl helps untangle complex IT. See their 2026 strategy for microservices, hybrid cloud, and reducing downtime by 15-20%.
Kyndryl expands its partner ecosystem in 2026. See how new alliances impact hybrid cloud, AI, and cybersecurity for your enterprise IT.
AI investment surges to $300 billion by 2026. See what areas like generative AI and specialized hardware are getting funding, and why it matters.